Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marianna Zipeto"'
Autor:
Stefano Cairo, Maria Mancini, Mara Gilardi, Karin Abarca Heidemann, Michael Ritchie, Christine Baer, Gilad Silberberg, Marianna Zipeto, Hsiu-Wen Tsai, Kurtis Cruz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/897e041f79d7408ebbaa04e10c8eefbf
Autor:
Stefano Cairo, Maria Mancini, Samaneh Kamali, Mara Gilardi, Abhay Andar, Karin Abarca Heidemann, Michael Ritchie, Taylor Light, Vaishnavi Sambandam, Nathan Alban, Yamini Nallana, Salma Shaik, Brandon Walling, Christine Baer, Gilad Silberberg, Veena Jagannathan, Marianna Zipeto
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/52d227321f39401b86f897c1dd96e629
Autor:
Stefano Cairo, Mara Gilardi, Michael Ritchie, Gilad Silberberg, Marianna Zipeto, Clare Killick-Cole, Haia Khouri, Alex Moreau
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/8ff4090f8b67473f801fa59717343acb
Autor:
Stefano Cairo, Mara Gilardi, Brandon Walling, Marianna Zipeto, Alex Moreau, Kiave Yune Ho Wang Yin, Nektaria Papadopoulou, Sebastian Brabetz, David DeOrnellis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b8f57b3703c1429e8b58dc146066e335
Autor:
Jennifer M. Atkinson, Megan Yates, Daniel D. Brown, Jagmohan Hooda, Rohit Bhargava, Paolo Schiavini, Marianna Zipeto, Steffi Oesterreich, ADRIAN V. LEE
Publikováno v:
Cancer Research. 83:P3-08
Background Most breast cancers (~85%) are of no special histologic subtype (NST), and the most common special subtype is invasive lobular cancer (ILC). ILC accounts for 10-15% of all breast cancers, and there will be ~40,000 new cases in 2022 in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c66fb4264506db44c01ce34ed7616bd0
https://doi.org/10.1158/1538-7445.sabcs22-p3-08-10
https://doi.org/10.1158/1538-7445.sabcs22-p3-08-10
Autor:
Gilad Silberberg, Brandon Walling, Amy Wesa, Alessandra Audia, Ido Sloma, Yi Zeng, Guanghui Han, Jia Tang, Paige Pammer, A’ishah Bakayoko, Xuan Ren, Daniel Ciznadija, Bandana Vishwakarma, Yaron Mosesson, Marianna Zipeto, Michael Ritchie
Despite considerable progress made in improving therapeutic strategies, the overall survival for patients diagnosed with various cancer types remains low. Further, patients often cycle through multiple therapeutic options before finding an effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c707f615650caa1ede4c0ebad5dba96
https://doi.org/10.1101/2022.06.14.495846
https://doi.org/10.1101/2022.06.14.495846
Autor:
Gilad Silberberg, Clare Killick-Cole, Yaron Mosesson, Haia Khoury, Xuan Ren, Mara Gilardi, Daniel Ciznadija, Paolo Schiavini, Marianna Zipeto, Michael Ritchie
Publikováno v:
Cancer Research. 83:854-854
The overall survival of patients diagnosed with Pancreatic Cancer remains low. Initial responses to current therapeutic interventions are below 50%, leading to a high mortality rate shortly after diagnosis. To date, only a companion diagnostic, non-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b90ad1dea12b27953a52b11e215b2393
https://doi.org/10.1158/1538-7445.am2023-854
https://doi.org/10.1158/1538-7445.am2023-854
Autor:
Vaishnavi Sambandam, Sharvari Inamdar, Haoting Hsu, Brandon Walling, Paolo Schiviani, Abhay Andar, Marianna Zipeto, Michael Ritchie, Karin Abarca Heidemann, Maria Mancini
Publikováno v:
Cancer Research. 83:207-207
Multiple Myeloma (MM) is a heterogeneous malignancy characterized by abnormal clonal plasma cell infiltration in the bone marrow. It is the second most common hematologic malignancy, after non-Hodgkin’s Lymphoma. This deadly disease globally affect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::705398210b8884497f016856db68b3ee
https://doi.org/10.1158/1538-7445.am2023-207
https://doi.org/10.1158/1538-7445.am2023-207
Autor:
Gilad Silberberg, Bandana Vishwakarma, Paul Heverly, Marianna Zipeto, David DeOrnellis, Michael Ritchie
Publikováno v:
Cancer Research. 82:3236-3236
The overall survival of patients diagnosed with Ovarian Cancer remains low. The current initial treatment regimen for patients with newly diagnosed advanced ovarian cancer includes the use of paclitaxel and carboplatin in combination with surgical cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::367af4b5ae037531379a6fa759b87d22
https://doi.org/10.1158/1538-7445.am2022-3236
https://doi.org/10.1158/1538-7445.am2022-3236
Autor:
Gilad Silberberg, Bandana Vishwakarama, Brandon Walling, Chelsea Riveley, Alessandra Audia, Marianna Zipeto, Ido Sloma, Amy Wesa, Michael Ritchie
Publikováno v:
Cancer Research. 82:3907-3907
The overall survival of patients diagnosed with Acute Myeloid Leukemia (AML) remains low. While initial responses to therapy are favorable, the duration of response is short and overcoming therapeutic resistance has proven difficult. A better underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3f664cda9527feae2724038ad51a9a7
https://doi.org/10.1158/1538-7445.am2022-3907
https://doi.org/10.1158/1538-7445.am2022-3907